Ullah Sadeeq, Chen Yong, Wu Chunyan, Abbas Yasir, Zhong Yangqing, Chen Xiaohui, Tan Junyin, Cheng Hefa, Li Lu
Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University Dongguan 523808 China
Department of Medical Laboratory, Affiliated Cancer Hospital of Chengdu Medical College, Chengdu Seventh People's Hospital Chengdu 610231 China.
RSC Adv. 2025 Jul 7;15(29):23187-23222. doi: 10.1039/d5ra01711d. eCollection 2025 Jul 4.
Bacteria employ biofilm formation as a survival strategy, characterized by the self-assembly of cells into 3D architectures encapsulated in an extracellular polymeric substance (EPS) that results in reduced antibiotic efficacy, increased tolerance, and emergence of multidrug resistance phenotypes. To overcome this challenge, persistent efforts are directed toward developing cutting-edge approaches and agents that rejuvenate antibiotic efficacy, mitigate biofilm formation, and eradicate biofilm-associated bacterial infections. Within this framework, nanotechnology has emerged as a pivotal tool for developing innovative functional materials with tailored attributes, exhibiting substantial potential in addressing the global health challenge of antibiotic resistance and biofilm-associated infections. This updated review article provides a comprehensive overview, commencing with a thorough analysis of biofilm formation and its implications, followed by a critical evaluation of cutting-edge strategies derived from recent research advancements. Our discussion encompasses novel strategies, including traditional nanomaterials, micro-nanobubbles, multifunctional nanozyme-mimetic platforms, artificial phage-like structures, and sophisticated nano-microrobotic systems. Each strategy is assessed for its potential to effectively target biofilms, enhance antimicrobial penetration, and restore antibiotic susceptibility. We anticipate that this timely review will inform and inspire innovative research directions, focusing on the rational design and application of advanced nanomaterials for targeted biofilm modulation and efficacious treatment, thereby advancing healthcare solutions.
细菌将生物膜形成作为一种生存策略,其特征是细胞自组装成三维结构,被包裹在细胞外聚合物(EPS)中,这导致抗生素疗效降低、耐受性增加以及多重耐药表型的出现。为了克服这一挑战,人们不断努力开发前沿方法和药物,以恢复抗生素疗效、减轻生物膜形成并根除与生物膜相关的细菌感染。在此框架内,纳米技术已成为开发具有定制属性的创新功能材料的关键工具,在应对抗生素耐药性和与生物膜相关感染的全球健康挑战方面展现出巨大潜力。这篇更新的综述文章提供了全面概述,首先对生物膜形成及其影响进行深入分析,接着对源自近期研究进展的前沿策略进行批判性评估。我们的讨论涵盖了新策略,包括传统纳米材料、微纳米气泡、多功能纳米酶模拟平台、人工噬菌体样结构以及复杂的纳米微机器人系统。对每种策略有效靶向生物膜、增强抗菌渗透以及恢复抗生素敏感性的潜力进行了评估。我们预计,这篇及时的综述将为创新研究方向提供信息并带来启发,重点关注先进纳米材料的合理设计和应用,以实现靶向生物膜调控和有效治疗,从而推动医疗保健解决方案的发展。
Arch Ital Urol Androl. 2025-6-30
JBI Database System Rev Implement Rep. 2016-4
Cochrane Database Syst Rev. 2017-2-9
Health Technol Assess. 2024-10
Cochrane Database Syst Rev. 2021-10-27
Cochrane Database Syst Rev. 2016-10-4
Acc Chem Res. 2025-6-17
Cochrane Database Syst Rev. 2012-3-14
Antibiotics (Basel). 2025-2-18
Nanoscale. 2025-2-6
ACS Nano. 2024-11-26
Adv Healthc Mater. 2025-3
Adv Healthc Mater. 2025-3